Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | EOG | Common Stock | Options Exercise | $4.45M | +64.1K | +8.88% | $69.43 | 786K | Mar 16, 2022 | Direct | |
transaction | EOG | Common Stock | Disposed to Issuer | -$4.45M | -39.7K | -5.05% | $112.24 | 747K | Mar 16, 2022 | Direct | |
transaction | EOG | Common Stock | Tax liability | -$975K | -8.68K | -1.16% | $112.24 | 738K | Mar 16, 2022 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | EOG | Stock Appreciation Rights | Options Exercise | $0 | -64.1K | -100% | $0.00* | 0 | Mar 16, 2022 | Common Stock | 64.1K | $69.43 | Direct | F1 |
Id | Content |
---|---|
F1 | The SARs granted became exercisable in 25 percent increments beginning one year from the September 28, 2015 date of grant and on each of the next three grant date anniversaries. The SARs granted became fully exercisable on September 28, 2019. This exercise did not involve any open-market sale of the Issuer's Common Stock. |